BioSpace News Archive

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of Accugenix® Next Generation Sequencing for Bacterial Identification and Fungal Identification (Accugenix® NGS).

Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the company will host a conference call and live audio webcast on Tuesday, May 9 at 4:30 p.m. EDT to report financial results for first quarter 2023.

Acer Therapeutics Inc. (Nasdaq: ACER) today announced an update on progress in support of its commercial launch of OLPRUVA™ (sodium phenylbutyrate) for oral suspension, including drug availability now expected earlier than anticipated in mid-June 2023, subject to additional capital.

Evoke Pharma, Inc. (NASDAQ: EVOK) announced that its recently issued U.S. patent related to GIMOTI, No. 11,628,150 is now listed in the U.S. Food and Drug Administration (FDA) publication, “Approved Drug Products with Therapeutic Equivalence Evaluations”, commonly known as the “Orange Book”.

Altamira Therapeutics (“Altamira” or the “Company”) (Nasdaq:CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, today announced that its founder, chairman, and CEO Thomas Meyer will be presenting at the Sidoti Micro-Cap Conference, being held virtually on May 10 - 11, 2023.

Nusano, Inc. announced Gregory Moffitt, PhD, Director of Target Development at Nusano, will present an overview of the company’s breakthrough production platform to the European Cooperation in Science and Technology Astatine-211 Working Group on May 4, 2023.

Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced financial results for the first quarter ended March 31, 2023.

sanofi-aventis Canada Inc. (Sanofi Canada) is pleased to announce that Health Canada has issued a Notice of Compliance (“NOC”) for Libtayo® (cemiplimab) in combination with platinum-based chemotherapy for the first-line treatment of adult patients with advanced non-small cell lung cancer (NSCLC).

On May 6, 2023, the Lennox-Gastaut Syndrome (LGS) Foundation will mobilize families, friends, and communities around the world to ‘Step Towards the Cures, Together’ at their 8th Annual Walk ‘n’ Wheel for LGS Research.

Flatiron Health announced a new collaboration today with Sanofi in their pursuit to redesign the clinical trial experience for sponsors, sites, and patients in the therapeutic area of oncology.